Hologic stopped manufacturing the device after reports of serious adverse events in patients who had the markers implanted in breast tissue.

Hologic Inc. has received a warning letter from the Food and Drug Administration regarding its BioZorb product line, even ...

The court concluded genuine issues of material fact existed regarding whether an advanced warning of the alleged risks of a ...

BioZorb, a medical device manufacturer, could not dodge the majority of the negligence and breach of warranty claims brought ...

Hologic (NASDAQ:HOLX) has recalled its implantable BioZorb and BioZorb LP Markers over concerns that they can cause irritation, infection and other health complications. The FDA said the devices ...